MX2018016033A - Metodo para purificar eritropoyetina pegilada. - Google Patents

Metodo para purificar eritropoyetina pegilada.

Info

Publication number
MX2018016033A
MX2018016033A MX2018016033A MX2018016033A MX2018016033A MX 2018016033 A MX2018016033 A MX 2018016033A MX 2018016033 A MX2018016033 A MX 2018016033A MX 2018016033 A MX2018016033 A MX 2018016033A MX 2018016033 A MX2018016033 A MX 2018016033A
Authority
MX
Mexico
Prior art keywords
erythropoietin
employing
residue
ethylene glycol
cation exchange
Prior art date
Application number
MX2018016033A
Other languages
English (en)
Inventor
Falkenstein Roberto
Spensberger Bernhard
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2018016033A publication Critical patent/MX2018016033A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361Ion-exchange
    • B01D15/362Cation-exchange
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/505Erythropoietin [EPO]

Abstract

En la presente se reporta un método para la purificación de una proteína que comprende eritropoyetina y un residuo único de poli(etilenglicol) a partir de productos secundarios de reacción o material inicial que no ha reaccionado, por un método de cromatografía de intercambio catiónico. Se ha encontrado que al usar un material de cromatografía de intercambio catiónico ToyopearlMR SP-650 y usando una segunda etapa de lavado con un valor de pH incrementado en comparación con la primera etapa de lavado se puede obtener una proteína de fusión de eritropoyetina y un residuo único de poli(etilenglicol) en una etapa única con alta pureza y rendimiento, y adecuado para aplicaciones a gran escala.
MX2018016033A 2016-07-15 2017-07-13 Metodo para purificar eritropoyetina pegilada. MX2018016033A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16179755 2016-07-15
PCT/EP2017/067790 WO2018011381A1 (en) 2016-07-15 2017-07-13 Method for purifying pegylated erythropoietin

Publications (1)

Publication Number Publication Date
MX2018016033A true MX2018016033A (es) 2019-05-13

Family

ID=56497564

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018016033A MX2018016033A (es) 2016-07-15 2017-07-13 Metodo para purificar eritropoyetina pegilada.

Country Status (16)

Country Link
US (2) US20190300567A1 (es)
EP (1) EP3484911B1 (es)
JP (2) JP7177035B2 (es)
KR (2) KR20220158870A (es)
CN (1) CN109415427A (es)
AU (1) AU2017295037B2 (es)
BR (1) BR112018076390A2 (es)
CA (1) CA3027143A1 (es)
ES (1) ES2841648T3 (es)
HR (1) HRP20202077T1 (es)
IL (1) IL264153B (es)
MX (1) MX2018016033A (es)
PL (1) PL3484911T3 (es)
SG (1) SG11201811553UA (es)
SI (1) SI3484911T1 (es)
WO (1) WO2018011381A1 (es)

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118796A (en) 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
FR2646438B1 (fr) 1989-03-20 2007-11-02 Pasteur Institut Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
DK0747485T3 (da) 1989-11-06 1999-08-16 Cell Genesys Inc Fremstilling af proteiner ved anvendelse af homolog rekombination
EP0779362B2 (en) 1989-12-22 2012-06-13 Laboratoires Serono SA DNA constructs for endogenous gene activation and expression modification
JPH04218000A (ja) 1990-02-13 1992-08-07 Kirin Amgen Inc 修飾ポリペプチド
JP3051145B2 (ja) 1990-08-28 2000-06-12 住友製薬株式会社 新規なポリエチレングリコール誘導体修飾ペプチド
DE4118912C1 (es) 1991-06-08 1992-07-02 Biotest Pharma Gmbh, 6072 Dreieich, De
US5733761A (en) 1991-11-05 1998-03-31 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
PT101031B (pt) 1991-11-05 2002-07-31 Transkaryotic Therapies Inc Processo para o fornecimento de proteinas por terapia genetica
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
WO1994001451A2 (en) 1992-07-13 1994-01-20 Bionebraska, Inc. Method for modification of recombinant polypeptides
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
JPH08176133A (ja) * 1994-12-26 1996-07-09 Takeda Chem Ind Ltd L−アスコルビン酸の精製法
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
CN103641885A (zh) * 1998-05-06 2014-03-19 基因技术股份有限公司 用离子交换层析纯化蛋白质
ES2204509T3 (es) 1999-01-29 2004-05-01 F. Hoffmann-La Roche Ag Conjugados de gcsf.
JO2291B1 (en) * 1999-07-02 2005-09-12 اف . هوفمان لاروش ايه جي Erythropoietin derivatives
CZ299516B6 (cs) 1999-07-02 2008-08-20 F. Hoffmann-La Roche Ag Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
DE60122286T2 (de) 2000-02-11 2007-08-02 Merck Patent Gmbh Steigerung der zirkulierenden halbwertzeit von auf antikörpern basierenden fusionsproteinen
US20050100991A1 (en) 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
CA2496060C (en) 2002-09-11 2015-08-04 Genentech, Inc. Protein purification by ion exchange chromatography
US7610156B2 (en) 2003-03-31 2009-10-27 Xencor, Inc. Methods for rational pegylation of proteins
US20050008649A1 (en) 2003-06-02 2005-01-13 University Of Miami Chimeric molecules and methods of use
AR067537A1 (es) * 2007-07-17 2009-10-14 Hoffmann La Roche Purificacion de polipeptidos pegilados
EP3441402A1 (en) * 2007-10-30 2019-02-13 Genentech, Inc. Antibody purification by cation exchange chromatography
DE102008002209A1 (de) * 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur Aufreinigung von Erythropoietin
CA2736141C (en) * 2008-09-23 2018-03-20 F. Hoffmann-La Roche Ag Purification of erythropoietin
JP5788803B2 (ja) * 2008-12-02 2015-10-07 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー ポリペプチド精製
JP5735650B2 (ja) * 2010-09-14 2015-06-17 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Peg化エリスロポエチンを精製するための方法

Also Published As

Publication number Publication date
AU2017295037B2 (en) 2021-07-22
IL264153B (en) 2021-09-30
KR20190026759A (ko) 2019-03-13
WO2018011381A1 (en) 2018-01-18
BR112018076390A2 (pt) 2019-03-26
US20190300567A1 (en) 2019-10-03
JP2019524726A (ja) 2019-09-05
JP2023015257A (ja) 2023-01-31
KR20220158870A (ko) 2022-12-01
IL264153A (en) 2019-02-28
CA3027143A1 (en) 2018-01-18
SI3484911T1 (sl) 2021-02-26
EP3484911A1 (en) 2019-05-22
KR102470282B1 (ko) 2022-11-24
EP3484911B1 (en) 2020-11-04
CN109415427A (zh) 2019-03-01
US20210155655A1 (en) 2021-05-27
PL3484911T3 (pl) 2021-03-08
HRP20202077T1 (hr) 2021-02-19
JP7177035B2 (ja) 2022-11-22
ES2841648T3 (es) 2021-07-08
SG11201811553UA (en) 2019-01-30
AU2017295037A1 (en) 2019-01-24

Similar Documents

Publication Publication Date Title
MX342444B (es) Metodo para purificar eritropoyetina conjugada con polietilenglicol (peg).
MX2018001404A (es) Sistema de produccion/proceso de producción para acido acrilico y sus precursores.
MY172391A (en) Processes for preparing dihydropyrimidine derivatives and intermediates thereof
WO2014149387A8 (en) Solid phase peptide synthesis processes and associated systems
WO2015024739A3 (en) Detergent composition comprising protease variants
WO2015014790A3 (en) Protease variants and polynucleotides encoding same
WO2014178078A3 (en) Novel cloning, expression & purification method for the preparation of ranibizumab
EA201400850A1 (ru) Альфа-амилаза
MX358963B (es) Polipeptidos con actividad proteasa.
MX364390B (es) Uso de polipeptidos que tienen actividad proteasa en alimentos para animales y detergentes.
MX2012007868A (es) Metodo para preparar sales de acido tetrazol-mentasulfonico, y un nuevo compuesto utilizado en las mismas.
MY156181A (en) Method and system for producing high-purity hydrogen chloride
MX2019005254A (es) Proceso para la purificacion de pirazolpiridazinas.
WO2014122161A3 (en) Use of polypeptides having protease activity in animal feed
MX2014003403A (es) Polipeptidos que poseen actividad proteasa y polinucleotidos que los codifican.
MX2018016033A (es) Metodo para purificar eritropoyetina pegilada.
MX363360B (es) Polipéptidos que poseen actividad proteasa y polinucleótidos que los codifican.
MX351284B (es) Polipeptidos con actividad proteasa.
MY171770A (en) An apparatus for continuous separation of valine and a method for continuous separation of valine using the same
WO2014102834A3 (en) Process for lurasidone
MY170005A (en) Beta-mercaptoethanol synthesis
MX2017009714A (es) Metodos para producir compuesto de pirazin carboxamida e intermediario sintetico del mismo.
EA201301294A1 (ru) Получение высокочистых мультисубъединичных белков, таких как антитела, в трансформированных микроорганизмах, например pichia pastoris
MX2016005264A (es) Procedimiento para purificar darbepoyetina alfa.
WO2016084100A3 (en) Novel and efficient method for large scale synthesis of romidepsin